DCRI Year in Review

DCRI Year in Review

As we gear up for another exciting year of clinical research, we take time to reflect on the insights we have drawn and shared with the broader community in 2018. We invite you to explore some of our best insights from the past year as we deliver on our mission to share knowledge that improves the care of patients around the world.


Califf Honored at AHA 2018

Robert Califf, MD, received the Eugene Braunwald Award for Academic Mentoring.


Pediatric Trials Network Renewed For Next 8 Years

Can Optimism
Impact Outcome?

Alexander Fanaroff, MD, found that angina patients who were more optimistic were less likely to have additional procedures or be hospitalized.


Answering Questions About Dialysis Guidelines

Do current guidelines for treating patients with end-stage renal disease lead to better outcomes? The HiLo Trial, led by Myles Wolf, MD, aims to find out.


Innovations in Study Coordination for ECHO

This year, several DCRI faculty and staff working on the Environmental influences on Child Health Outcomes (ECHO) Program collaborated on an article about the DCRI’s role in ECHO.


Shaping CEC
Best Practices

DCRI and the Stanford Center for Clinical Research hosted a two-day CEC Summit that focused on safety, best practices, and quality standards for clinical events classification.


Changing Clinical Practice

Implementation science, or reducing the gap between discoveries in research and clinical practice, can improve outcomes for patients, says Christopher Granger, MD.


"I think it extends our reach. When we partner with the people who are putting out these databases, we have a seat at the table."

"I think it extends our reach. When we partner with the people who are putting out these databases, we have a seat at the table."

-Lisa Wruck, PhD

Wruck sees great opportunities to innovate clinical trials through the usage of electronic health record (EHR) data.

Reed Johnson

Reed Johnson, PhD, Honored by ISPOR

Johnson received a Lifetime Achievement Award for his work in stated preferences research.


Engaging Participants in Clinical Research

The DCRI's Research Together program treats participants in studies and trials as partners in the research.


30 Million Adults

30 Million Adults


in the U.S. live with chronic kidney disease. New study EMPA-KIDNEY will examine a potential new treatment.



$2,745 Saved per Patient

$2,745 Saved per Patient


The VERITAS trial found cost savings for patients who were treated with virtual therapy using VERA technology when compared to usual care with traditional physical therapy.

DCRI at TCT 2018

Sunil Rao, MD, shares TCT’s approach to interventional cardiology, discusses the most compelling trial to come out of the conference, and recalls how #radialfirst began.

"We're very hopeful that if we can use these machine learning technologies on electronic health care records, that we can actually optimize how doctors are treating patients."

-David Carlson, PhD

Carlson shares insights on how to leverage machine learning to improve clinical research and health care delivery.


Applying Behavioral Economics to Research

The Behavioral Research Intervention Science Center will use behavioral economics to increase participant engagement in studies.

300,000 Children in the U.S. Have Juvenile Idiopathic Arthritis

The Patient-Centered Outcomes Research Institute awarded $7 million to Laura Schanberg, MD, to study treatments for the condition.

Sheng Luo

Predicting Progression

Sheng Luo, PhD, developed an algorithm to better predict Alzheimer's disease progression.


Susanna Naggie, MD, Receives IDSA Award

Naggie was given an award for extraordinary infectious disease researchers under 45.


Curtis Named ACMI Fellow

Lesley Curtis, PhD, was inducted into the American College of Medical Informatics.


What Are the Barriers to Adopting Therapies?

What Are the Barriers to Adopting Therapies?


Cost, time spent filling out paperwork, and patient and provider education can all slow down the adoption process.

"We realize that heart rhythm disorders have a 24/7 impact. Knowing the overall burden of an arrhythmia that a patient has is really important."

-Jonathan Piccini, MD, MHS

Piccini discusses the role of the DCRI’s Arrhythmia Core Lab in clinical research.

Data and Innovation in Gastroenterology

Deborah Fisher, MD, discusses a range of topics, including the optical sensor her team is developing to detect abnormalities.


Albiglutide Effective in Lowering Heart Risk


When compared to placebo, the drug was found to be superior in reducing the risk of major adverse cardiovascular events by 22 percent.


Wilder Honored By AASLD

Julius Wilder, MD, PhD, received the Clinical, Translational, and Outcomes Research Award for young researchers studying liver disease.


Pain Management From A Personalized Perspective

Steven George, PhD, discusses creating individualized treatment plans to decrease opioid use.


A Focus on Precision Medicine

A Focus on Precision Medicine


Researchers at the DCRI want to figure out how data can determine which treatments work best for which people to administer individualized treatment plans.


“We should consider copayment reductions as part of broader initiatives to improve medication use and clinical outcomes."

-Tracy Wang, MD, MS, MHS


DCRI Receives CRO Leadership Award for 3rd Year in a Row

"We need to look at policies that are going to have a more disruptive impact on our society."

Sarah Armstrong, MD, makes recommendations about what actions need to be taken to curb childhood obesity.


Nutrition's Role In Surgery

In this podcast, Paul Wischmeyer, MD, discusses best practices for perioperative nutrition with scientists and clinicians.


Registries to Advance Research


Scott Palmer, MD, discusses the IPF-PRO registry, which was created to examine outcomes for fibrosis patients.


Reducing the Risk of Kidney Stones


The NIDDK has awarded an additional $1.3 million over three years to Chuck Scales, MD, and Hussein Al-Khalidi, PhD, to support the Prevention of Urinary Stones with Hydration (PUSH) trial.


Investigators Test New Influenza Vaccine

Investigators Test New Influenza Vaccine


The vaccine has the potential to be effective against multiple strains of the virus for five or more years at a time.